Citeline Podcasts

In this episode, HBW Insight speaks to The Exponential Club’s Nick Tate about the impact of artificial intelligence and digitalization on consumer health and wellness. Having worked in both marketing and OTC, most recently leading Haleon’s incubator business, Haleon NEXT, Tate is perfectly placed to explain where industry is now with regards to digital health, and where it might be in the near future. The importance of data interoperability and of dialogue between governments, companies and consumers is discussed, along with ChatGPT and AI anxiety and the need for philosophers.

Pink Sheet reporters and editors discuss the nearly wide open 2024 FDA advisory committee calendar, CMS’s impact on Florida’s drug importation plan, and the FDA’s many missed user fee goals in 2023.

More On These Topics From The Pink Sheet

The Sudden Stop In US FDA Advisory Committees: https://pink.citeline.com/PS149641/The-Sudden-Stop-In-US-FDA-Advisory-Committees

Drug Importation And Medicaid: Trump Era Guidance Likely Disincentivizes Use: https://pink.citeline.com/PS149635/Drug-Importation-And-Medicaid-Trump-Era-Guidance-

Likely-Disincentivizes-Use

US FDA’s Missed User Fee Goals Spiked In 2023 – And Not Just Because Of COVID-19: https://pink.citeline.com/PS149629/US-FDAs-Missed-User-Fee-Goals-Spiked-In-2023--And-Not-Just-Because-Of-COVID-19

VelaVigo founder and CEO Jing Li in Shanghai joins guest speaker Leon Tang in the US and Brian Yang in Beijing to discuss what stood out in this special JPM-focused episode of Scrip's Chinese-language podcast.

https://scrip.citeline.com/SC149656/ChineseLanguage-Podcast-JPM-China-Biotech-Going-Global-2024-Outlook

#pharma #biotech #JPM2024 #China #lifesciences

（日本語版）今回取り上げた記事はこちら

「J.P. Morgan 2024: Optimism With An Undercurrent Of Tension（J.P.モルガン2024年：緊張をはらんだ楽観論）」

https://www.citeline.com/ja-jp/resources/jp-morgan-2024-optimism-with-an-undercurrent-of-tension

※全文の閲覧には情報の登録（無料）が必要です。

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。

（英語版）

https://scrip.citeline.com/SC149614/JP-Morgan-2024-Optimism-With-An-Undercurrent-Of-Tension

※全文の閲覧には購読（有料）が必要です。

世界の製薬ビジネスメディアScrip（スクリップ）とは？

https://www.citeline.com/ja-jp/products-services/commercialization/scrip

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: major takeaways and highlights from the J.P. Morgan meeting; J&J bets on ADCs with Ambrx buy; the Indian GLP-1 battleground; and Scrip asks what 2024 holds for business strategy and leadership.

https://scrip.citeline.com/SC149628/Quick-Listen-Scrips-Five-MustKnow-Things

Pennine Health Talks Sustainability Compliance and ESG Initiatives by Citeline

Pink Sheet reporter and editors discuss a new pilot project allowing collaborative reviews of gene therapies by multiple regulators (:42), predictions for the upcoming year by current and former US FDA leaders (11:12), and the FDA commissioner’s take on artificial intelligence (21:23).

More On These Topics From The Pink Sheet

Don’t Call It Project Orbis: CoGenT Global Will Pilot Collaborative Review Of Gene Therapies: https://pink.citeline.com/PS149607/Dont-Call-It-Project-Orbis-CoGenT-Global-Will-Pilot-Collaborative-Review-Of-Gene-Therapies

EMA To Become Observer Of FDA’s Project Orbis Early This Year: https://pink.citeline.com/PS149579/EMA-To-Become-Observer-Of-FDAs-Project-Orbis-Early-This-Year

New Year’s Predictions From FDA Leadership Past And Present: GLP-1s, Mental Health, Big Data: https://pink.citeline.com/PS149583/New-Years-Predictions-From-FDA-Leadership-Past-And-Present-GLP1s-Mental-Health-Big-Data

US FDA’s Role In Artificial Intelligence/Machine Learning Development Is ‘Convener,’ Califf Says: https://pink.citeline.com/PS149608/US-FDAs-Role-In-Artificial-IntelligenceMachine-Learning-Development-Is-Convener-Califf-Says

In the latest episode of the In Vivo podcast, non-executive chair Peter Bains and Owain Millington, vice president of immunology and head of preclinical, discuss ILC Therapeutics’ platform technology, financing plans as well as the pros and cons of running a startup biotech in the UK.

Join Jung Won Shin for this Korean-language mini podcast talking about a report from Citeline's Datamonitor Healthcare.

Datamonitor Healthcare의 비만치료제시장 분석리포트를 요약한 내용입니다.

https://www.biomedtracker.com/reportdetail.cfm?reportid=863

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: 2023 drug launch highlights; the M&A outlook for the new year; AstraZeneca’s China cell therapy acquisition; the pre-Christmas deal flow; and India at a turning point for ADCs?

https://scrip.citeline.com/SC149606/Quick-Listen-Scrips-Five-MustKnow-Things